New Environmental Standards For Pharmaceutical Industry Take Effect
This article was originally published in PharmAsia News
Executive Summary
The State Environmental Protection Administration of China has published the discharge standards of pollutants for the pharmaceutical industry. Coming into force on August 1, the new standards cover all six subcategories of the industry, including extraction products, TCM, biopharmaceuticals, mixing/compounding formulations, fermentation products and chemical synthesis products. According to the content details, the main indices are stricter than those of the U.S., with the discharge levels of chemical oxygen demand, biochemical oxygen demand and total cyanide close to the most rigorous EU standards. China will give differential treatment to new and old enterprises; the latter may enjoy a two-year transition period while new firms will need to implement the standards from the start. (Click here for more - Chinese Language)
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.